Andrew A. Hack, Ph.D. - Publications

Affiliations: 
2000 University of Chicago, Chicago, IL 
Area:
Cell Biology, Molecular Biology, Genetics, Pathology

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2004 Allikian MJ, Hack AA, Mewborn S, Mayer U, McNally EM. Genetic compensation for sarcoglycan loss by integrin alpha7beta1 in muscle. Journal of Cell Science. 117: 3821-30. PMID 15252120 DOI: 10.1242/Jcs.01234  0.704
2004 Wheeler MT, Korcarz CE, Collins KA, Lapidos KA, Hack AA, Lyons MR, Zarnegar S, Earley JU, Lang RM, McNally EM. Secondary coronary artery vasospasm promotes cardiomyopathy progression. The American Journal of Pathology. 164: 1063-71. PMID 14982859 DOI: 10.1016/S0002-9440(10)63193-8  0.552
2003 Wheeler MT, Collins KA, Korcarz CE, Hack AA, Zarnegar S, Lyons M, McNally EM. Reduction of secondary vasospasm limits cardiomyopathy progression Journal of the American College of Cardiology. 41: 218. DOI: 10.1016/S0735-1097(03)81599-1  0.416
2001 Porter JD, Merriam AP, Hack AA, Andrade FH, McNally EM. Extraocular muscle is spared despite the absence of an intact sarcoglycan complex in gamma- or delta-sarcoglycan-deficient mice. Neuromuscular Disorders : Nmd. 11: 197-207. PMID 11257478 DOI: 10.1016/S0960-8966(00)00171-1  0.709
2001 Cordier L, Gao GP, Hack AA, McNally EM, Wilson JM, Chirmule N, Sweeney HL. Muscle-specific promoters may be necessary for adeno-associated virus-mediated gene transfer in the treatment of muscular dystrophies. Human Gene Therapy. 12: 205-15. PMID 11177557 DOI: 10.1089/104303401750061267  0.66
2000 Cordier L, Hack AA, Scott MO, Barton-Davis ER, Gao G, Wilson JM, McNally EM, Sweeney HL. Rescue of skeletal muscles of gamma-sarcoglycan-deficient mice with adeno-associated virus-mediated gene transfer. Molecular Therapy : the Journal of the American Society of Gene Therapy. 1: 119-29. PMID 10933922 DOI: 10.1006/Mthe.1999.0019  0.705
2000 Hack AA, Lam MY, Cordier L, Shoturma DI, Ly CT, Hadhazy MA, Hadhazy MR, Sweeney HL, McNally EM. Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex. Journal of Cell Science. 113: 2535-44. PMID 10862711  0.684
2000 Hack AA, Groh ME, McNally EM. Sarcoglycans in muscular dystrophy. Microscopy Research and Technique. 48: 167-80. PMID 10679964 DOI: 10.1002/(Sici)1097-0029(20000201/15)48:3/4<167::Aid-Jemt5>3.0.Co;2-T  0.673
2000 Thompson TG, Chan YM, Hack AA, Brosius M, Rajala M, Lidov HG, McNally EM, Watkins S, Kunkel LM. Filamin 2 (FLN2): A muscle-specific sarcoglycan interacting protein. The Journal of Cell Biology. 148: 115-26. PMID 10629222 DOI: 10.1083/Jcb.148.1.115  0.611
1999 Hack AA, Cordier L, Shoturma DI, Lam MY, Sweeney HL, McNally EM. Muscle degeneration without mechanical injury in sarcoglycan deficiency. Proceedings of the National Academy of Sciences of the United States of America. 96: 10723-8. PMID 10485893 DOI: 10.1073/Pnas.96.19.10723  0.7
1998 Hack AA, Ly CT, Jiang F, Clendenin CJ, Sigrist KS, Wollmann RL, McNally EM. Gamma-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin. The Journal of Cell Biology. 142: 1279-87. PMID 9732288 DOI: 10.1083/Jcb.142.5.1279  0.702
Show low-probability matches.